Jeffrey E. Russel

Array ( [id] => 4507629 [patent_doc_number] => 07915223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Antimicrobial agents' [patent_app_type] => utility [patent_app_number] => 11/500461 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 32543 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915223.pdf [firstpage_image] =>[orig_patent_app_number] => 11500461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050929 [patent_doc_number] => 20070031474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Implantable preparations' [patent_app_type] => utility [patent_app_number] => 11/499723 [patent_app_country] => US [patent_app_date] => 2006-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9920 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031474.pdf [firstpage_image] =>[orig_patent_app_number] => 11499723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917235 [patent_doc_number] => 07323448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Antibacterial agents' [patent_app_type] => utility [patent_app_number] => 11/497277 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27726 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323448.pdf [firstpage_image] =>[orig_patent_app_number] => 11497277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873769 [patent_doc_number] => 20080200503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Macrocylic Inhibitors Of Hepatitis C Virus' [patent_app_type] => utility [patent_app_number] => 11/995888 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21411 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200503.pdf [firstpage_image] =>[orig_patent_app_number] => 11995888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220259 [patent_doc_number] => 20070161570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/490967 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18114 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161570.pdf [firstpage_image] =>[orig_patent_app_number] => 11490967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 574317 [patent_doc_number] => 07459428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Method of regulating glucose metabolism, and reagents related thereto' [patent_app_type] => utility [patent_app_number] => 11/487947 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19144 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459428.pdf [firstpage_image] =>[orig_patent_app_number] => 11487947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205589 [patent_doc_number] => 20070027071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/484925 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027071.pdf [firstpage_image] =>[orig_patent_app_number] => 11484925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057605 [patent_doc_number] => 20070060527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Orally administered small peptides synergize statin activity' [patent_app_type] => utility [patent_app_number] => 11/485620 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 35240 [patent_no_of_claims] => 191 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060527.pdf [firstpage_image] =>[orig_patent_app_number] => 11485620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411682 [patent_doc_number] => 07282484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 11/476524 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 18636 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282484.pdf [firstpage_image] =>[orig_patent_app_number] => 11476524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183510 [patent_doc_number] => 20070054864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'HCV Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/478337 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23440 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054864.pdf [firstpage_image] =>[orig_patent_app_number] => 11478337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 288821 [patent_doc_number] => 07547445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Crosslinkable macromers' [patent_app_type] => utility [patent_app_number] => 11/475438 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16911 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547445.pdf [firstpage_image] =>[orig_patent_app_number] => 11475438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253898 [patent_doc_number] => 20070135354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Hematopoietic stimulation' [patent_app_type] => utility [patent_app_number] => 11/474929 [patent_app_country] => US [patent_app_date] => 2006-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9831 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135354.pdf [firstpage_image] =>[orig_patent_app_number] => 11474929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198692 [patent_doc_number] => 20070298010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Stabilizing alkylglycoside compositions and methods thereof' [patent_app_type] => utility [patent_app_number] => 11/474055 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19534 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298010.pdf [firstpage_image] =>[orig_patent_app_number] => 11474055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923915 [patent_doc_number] => 20060241025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Biodegradable glucosamine-muramyl peptides for apoptosis modulation' [patent_app_type] => utility [patent_app_number] => 11/472059 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3669 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241025.pdf [firstpage_image] =>[orig_patent_app_number] => 11472059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859773 [patent_doc_number] => 20060229249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same' [patent_app_type] => utility [patent_app_number] => 11/471088 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10457 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229249.pdf [firstpage_image] =>[orig_patent_app_number] => 11471088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330518 [patent_doc_number] => 07511014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Cyclosporin galenic forms' [patent_app_type] => utility [patent_app_number] => 11/453504 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14519 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511014.pdf [firstpage_image] =>[orig_patent_app_number] => 11453504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160414 [patent_doc_number] => 20070173458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Neo-tryptophan' [patent_app_type] => utility [patent_app_number] => 11/452616 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16365 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173458.pdf [firstpage_image] =>[orig_patent_app_number] => 11452616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514161 [patent_doc_number] => 20090214467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'METHODS OF PROTECTING AGAINST APOPTOSIS USING LIPOPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/917494 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 13313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214467.pdf [firstpage_image] =>[orig_patent_app_number] => 11917494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858575 [patent_doc_number] => 08461110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders' [patent_app_type] => utility [patent_app_number] => 11/922043 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4815 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11922043 [rel_patent_id] =>[rel_patent_doc_number] =>)